An Update on Oral Therapies for Early COVID-19

$0.00

e focus of Dr. Klausner’s presentation will be on the state of the evidence of existing oral therapies for COVID-19.

Full Description

​We are pleased that our primary presenter will be Jeffrey D. Klausner, MD, MPH with the Division of Disease Prevention, Policy and Global Health at the University of Southern California’s Keck School of Medicine. The focus of Dr. Klausner’s presentation will be on the state of the evidence of existing oral therapies for COVID-19 outpatient treatment.

Additional information

Format

Video

Contributor

Jeffrey D. Klausner

Length

58 minutes

Publication Date

4/1/21

Source

Urgent Care Association